Evidence map›Paper›PMID 35780146›Full record

ReviewReproductive biology and endocrinology : RB&E2022

Follicle-stimulating hormone signaling in Sertoli cells: a licence to the early stages of spermatogenesis.

Jia-Ming Wang, Zhen-Fang Li, Wan-Xi Yang, Fu-Qing Tan

Open access · goldAbstract readReview
In one paragraph

Review in Reproductive biology and endocrinology : RB&E, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. miR-132-y TargetsBiomolecules · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. New Insight Into Male Infertility: Deviation From Basic Tenets of Life.Oxidative medicine and cellular longevity · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Sertoli cells as a hub in testicular development and male reproductive.Frontiers in cell and developmental biology · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jia-Ming Wang *The Sperm Laboratory, College of Life Sciences, Zhejiang University, Hangzhou, 310058, China.
Zhen-Fang Li *The Sperm Laboratory, College of Life Sciences, Zhejiang University, Hangzhou, 310058, China.
Wan-Xi YangThe Sperm Laboratory, College of Life Sciences, Zhejiang University, Hangzhou, 310058, China. wxyang@zju.edu.cn.
Fu-Qing TanThe First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China. drtfq@zju.edu.cn.
Zhejiang University · CN

Funding

National Natural Science Foundation of China 32072954Natural Science Foundation of Zhejiang Province, China LY20H040010
6 · The paper itself

Abstract

Follicle-stimulating hormone signaling is essential for the initiation and early stages of spermatogenesis. Follicle-stimulating hormone receptor is exclusively expressed in Sertoli cells. As the only type of somatic cell in the seminiferous tubule, Sertoli cells regulate spermatogenesis not only by controlling their own number and function but also through paracrine actions to nourish germ cells surrounded by Sertoli cells. After follicle-stimulating hormone binds to its receptor and activates the follicle-stimulating hormone signaling pathway, follicle-stimulating hormone signaling will establish a normal Sertoli cell number and promote their differentiation. Spermatogonia pool maintenance, spermatogonia differentiation and their entry into meiosis are also positively regulated by follicle-stimulating hormone signaling. In addition, follicle-stimulating hormone signaling regulates germ cell survival and limits their apoptosis. Our review summarizes the aforementioned functions of follicle-stimulating hormone signaling in Sertoli cells. We also describe the clinical potential of follicle-stimulating hormone treatment in male patients with infertility. Furthermore, our review may be helpful for developing better therapies for treating patients with dysfunctional follicle-stimulating hormone signaling in Sertoli cells.

Indexed as

Follicle Stimulating HormoneSertoli CellsSpermatogenesisAnimalsHumansMaleMeiosisMiceRatsSignal TransductionSpermatogoniaFollicle Stimulating HormoneFollicle-stimulating hormoneFSH treatmentSertoli cellSignaling pathwaySpermatogenesis

Identifiers

PMID35780146
PMCPMC9250200
OpenAlexW4283770323

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.